# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-048785
Filing Date
2025-11-04
Accepted
2025-11-04 16:02:57
Documents
99
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | bcrx-20250930.htm iXBRL | 10-Q | 1762503
2 | EX-10.3 | thackray-biocrystseparat.htm | EX-10.3 | 37385
3 | EX-10.4 | bcrx-20250930x10xqxex104.htm | EX-10.4 | 61514
4 | EX-31.1 | bcrx-20250930x10xqxex311.htm | EX-31.1 | 10725
5 | EX-31.2 | bcrx-20250930x10xqxex312.htm | EX-31.2 | 10694
6 | EX-32.1 | bcrx-20250930x10xqxex321.htm | EX-32.1 | 6089
7 | EX-32.2 | bcrx-20250930x10xqxex322.htm | EX-32.2 | 5853
13 |  | thackray-biocrystseparat001.jpg | GRAPHIC | 156835
14 |  | thackray-biocrystseparat002.jpg | GRAPHIC | 226300
15 |  | thackray-biocrystseparat003.jpg | GRAPHIC | 271904
16 |  | thackray-biocrystseparat004.jpg | GRAPHIC | 293170
17 |  | thackray-biocrystseparat005.jpg | GRAPHIC | 288710
18 |  | thackray-biocrystseparat006.jpg | GRAPHIC | 293586
19 |  | thackray-biocrystseparat007.jpg | GRAPHIC | 287560
20 |  | thackray-biocrystseparat008.jpg | GRAPHIC | 302364
21 |  | thackray-biocrystseparat009.jpg | GRAPHIC | 325757
22 |  | thackray-biocrystseparat010.jpg | GRAPHIC | 231686
23 |  | thackray-biocrystseparat011.jpg | GRAPHIC | 135217
| Complete submission text file | 0001628280-25-048785.txt |  | 13477245

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
8 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | bcrx-20250930.xsd | EX-101.SCH | 68491
9 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | bcrx-20250930_cal.xml | EX-101.CAL | 97230
10 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | bcrx-20250930_def.xml | EX-101.DEF | 349068
11 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | bcrx-20250930_lab.xml | EX-101.LAB | 807029
12 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | bcrx-20250930_pre.xml | EX-101.PRE | 586726
102 | EXTRACTED XBRL INSTANCE DOCUMENT | bcrx-20250930_htm.xml | XML | 1378316

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 251448845
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)